Post-Exposure Prophylaxis (PEP) | HIV Risk and Prevention ...
PEP is the use of antiretroviral drugs after a single high-risk event to stop HIV seroconversion. PEP must be started as soon as possible to be effective—and always within 72 hours of a possible exposure.
Pre-Exposure Prophylaxis (PrEP) | HIV Risk and Prevention ...
Pre-exposure prophylaxis (or PrEP) is medicine taken to prevent getting HIV. PrEP is highly effective for preventing HIV when taken as prescribed. PrEP reduces the risk of getting HIV from sex by about 99%. PrEP reduces the risk of getting HIV from injection drug use by at least 74%.
Post-Exposure Prophylaxis - HIV.gov
Nov 15, 2023 · HIV PEP, or post-exposure prophylaxis, is a short course of HIV medicines taken very soon after a possible exposure to HIV to prevent the virus from taking hold in your body. You must start it within 72 hours (3 days) after a possible exposure to HIV, or it won’t work.
Pre-Exposure Prophylaxis - HIV.gov
Jun 27, 2024 · What is PrEP? PrEP, or pre-exposure prophylaxis, is medicine people at risk for HIV take to prevent getting HIV from sex or injection drug use. PrEP can stop HIV from taking hold and spreading throughout your body. Currently, there are two FDA-approved daily oral medications for PrEP.
HIV pre-exposure prophylaxis - UpToDate
Oct 12, 2023 · The use of pre-exposure prophylaxis (PrEP) with antiretroviral therapy (ART) for those without HIV has proven to be an effective HIV prevention strategy. Among persons who are adherent to treatment, PrEP can reduce the risk of HIV transmission by greater than 99 percent [1], although rare infections may still occur [2-4].
Preventing HIV with PrEP | HIV | CDC - Centers for Disease ...
Jan 18, 2024 · PrEP (pre-exposure prophylaxis) is medicine (pills or shots) that reduces your chance of getting HIV. PrEP is for adults and adolescents without HIV who may be exposed to HIV through sex or injection drug use.
Pre-Exposure Prophylaxis (PrEP) to Prevent HIV
Pre-exposure prophylaxis, or PrEP, is a strategy in which people routinely take one or more antiretroviral drugs to reduce their chances of getting HIV. Two PrEP methods are currently licensed in the United States: oral combinations of daily antiretrovirals in a single pill, and a long-acting injectable antiretroviral administered once every ...